1217219-62-9
1217219-62-9
Chemical Structure
9-cis-Retinol acetate-d5
Synonym(s): 9-cis-Vitamin A acetate-d5;Zuretinol acetate-d5
- CAS No.: 1217219-62-9
- Formula:C22H27D5O2
- Molecular Weight:333.52
IUPAC Name: (2E,4E,6Z,8E)-9-(6,6-dimethyl-2-(methyl-d3)cyclohex-1-en-1-yl-3,3-d2)-3,7-dimethylnona-2,4,6,8-tetraen-1-yl acetate
InChIKey: QGNJRVVDBSJHIZ-DCNQKGDESA-N
SMILES: CC1(C(/C=C/C(C)=C\C=C\C(C)=C\COC(C)=O)=C(C([2H])(CC1)[2H])C([2H])([2H])[2H])C
Biological Activity: 9-cis-Retinol acetate-d5 is the deuterium labeled 9-cis-Retinol acetate. 9-cis-Retinol acetate is a retinal derivative[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
9-cis-Retinol acetate-d5 | 9-cis-Retinol acetate-d5 is the deuterium labeled 9-cis-Retinol acetate. 9-cis-Retinol acetate is a retinal derivative. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Retinyl acetate (Standard) | 98.23% | Retinyl acetate (Standard) is the analytical standard of Retinyl acetate. This product is intended for research and analytical applications. Retinyl acetate is a synthetic acetate ester form derived from retinol and has potential antineoplastic and chemo preventive activities. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Retinyl acetate-d4 | 99.4% | Retinyl acetate-d4 is the deuterium labeled Retinyl acetate. Retinyl acetate is a synthetic acetate ester form derived from retinol and has potential antineoplastic and chemo preventive activities. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Retinyl acetate-d3 | Retinyl acetate-d3 (ALK-001) is a deuterated Vitamin A. Retinyl acetate-d3 can be used for research of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Retinyl acetate | 99.30% | Retinyl acetate is a synthetic acetate ester form derived from retinol and has potential antineoplastic and chemo preventive activities. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]
- [2]. Hussain RM, Gregori NZ, Ciulla TA, Lam BL. Pharmacotherapy of retinal disease with visual cycle modulators. Expert Opin Pharmacother. 2018;19(5):471-481. [Content Brief]
